Owkin

Owkin provides a platform for life sciences companies, researchers, and hospitals that enables them to exchange medical information while retaining the privacy of patients. The platform also allows to simplify the process of drug discovery by providing AI insights from large datasets.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
  • Combo news

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
$  Share Price
Series B8 Jun 2022
***
***
$...
Corporate18 Nov 2021
***
***
$...
Series A1 Jul 2020
***
***
$...
Series A7 May 2020
***
***
$...
Series A7 Mar 2019
***
***
$...
Series A23 May 2018
***
***
$...
Series A16 Jan 2018
***
***
$...
Seed30 Oct 2016
***
***
$...

*** - To view the data, please log into your account or create a new one.

News related to Owkin

OwkinOwkin • 12 Sep 2023

Owkin and Tribun Health Launch Strategic Partnership to Accelerate ...

Moreover, Owkin customers and users will be able to benefit from Tribun Health's fully integrated software platform for research that streamlines pathology data ...

https://www.streetinsider.com/Accesswire/Owkin+and+Tribun+Health+Launch+Strategic+Partnership+to+Accelerate+Access+to+AI+Solutions+for+Diagnosis+and+Pharma+Research/22149217.html
OwkinOwkin • 11 Sep 2023

Owkin and Tribun Health Launch Strategic Partnership to Accelerate ...

Owkin and Tribun Health announce a strategic partnership to advance the development and global deployment of Artificial Intelligence (AI) Diagnostic and ...

https://finance.yahoo.com/news/owkin-tribun-health-launch-strategic-120000196.html
OwkinOwkin • 2 Mar 2022

Owkin welcomes leading immuno-oncology professor as Chief ...

NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) -- Owkin appointed Professor Vassili Soumelis as Chief Medical Officer and Eric Durand as SVP Data Science today, ...

https://uk.finance.yahoo.com/news/owkin-welcomes-leading-immuno-oncology-124600690.html
More (7)

Owkin Twitter